Analysts Set The Clorox Company (NYSE:CLX) Target Price at $146.43

The Clorox Company (NYSE:CLX) has been assigned an average rating of “Reduce” from the seventeen brokerages that are covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $146.43.

Several brokerages recently issued reports on CLX. Evercore ISI cut their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research report on Wednesday, May 1st. JPMorgan Chase & Co. lowered their target price on shares of Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Barclays cut their price target on shares of Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. Citigroup decreased their price objective on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th.

Institutional Trading of Clorox

Several hedge funds have recently made changes to their positions in CLX. CIBC Private Wealth Group LLC raised its stake in Clorox by 0.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after acquiring an additional 66 shares during the period. Lindbrook Capital LLC raised its position in shares of Clorox by 6.2% in the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock valued at $181,000 after purchasing an additional 69 shares during the period. First National Bank of Mount Dora Trust Investment Services lifted its stake in shares of Clorox by 3.2% during the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock valued at $322,000 after buying an additional 71 shares in the last quarter. Modera Wealth Management LLC boosted its holdings in Clorox by 1.4% in the 3rd quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock worth $672,000 after buying an additional 71 shares during the period. Finally, Czech National Bank grew its stake in Clorox by 0.3% in the 4th quarter. Czech National Bank now owns 21,718 shares of the company’s stock valued at $3,097,000 after buying an additional 71 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

Shares of CLX stock opened at $138.63 on Friday. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The firm has a fifty day simple moving average of $138.02 and a two-hundred day simple moving average of $144.15. Clorox has a 12 month low of $114.68 and a 12 month high of $169.14. The firm has a market capitalization of $17.22 billion, a PE ratio of 71.83, a price-to-earnings-growth ratio of 2.17 and a beta of 0.39.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm’s revenue was down 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.51 EPS. Analysts forecast that Clorox will post 5.84 EPS for the current fiscal year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.